Clinical Trial Update: A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing raltitrexed plus docetaxel versus docetaxel alone as second-line chemotherapy in gastric cancer; trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Raltitrexed (Raltitrexed)

Snippet

Sponsor: Hebei Tumor Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN